Developing a vaccine for Staphylococcus aureus
Official title: Task V28: Process Development and Master Bank Production for a Staph aureus Vaccine Candidate
Funded at Idt Biologika Gmbh · NIH-10475959 · Data updated 2026-11-12
This study is working on creating a new vaccine to help protect people from Staphylococcus aureus infections, which can be tough to treat because the bacteria resist many antibiotics, and it aims to make this vaccine safe and effective for future use.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Idt Biologika Gmbh NIH-funded |
| Lab location | 1 site (Dessau-Rosslau, Germany) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2021 |
| Award (this year) | $1,149,011 |
| NIH project number | 272201800011I-0-759302100001-1 |
| Project ID | NIH-10475959 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at high risk for Staphylococcus aureus infections, including those with weakened immune systems or chronic health conditions.
✕Less likely to help
Patients who are not at risk for Staphylococcus aureus infections or those who have already been vaccinated against it may not receive any benefit from this research.
What this research studies
This research focuses on the development and production of a vaccine candidate for Staphylococcus aureus, a significant infectious disease. The project involves planning, optimizing, and manufacturing the vaccine in compliance with regulatory standards for clinical trials. Patients may benefit from the eventual availability of a vaccine that could prevent infections caused by this bacteria, which is known for its resistance to many antibiotics. The research includes thorough assessments and audits to ensure the vaccine meets safety and efficacy standards.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that significantly reduces the incidence of Staphylococcus aureus infections.
How similar studies have gone: Other research has shown success in developing vaccines for various infectious diseases, indicating a promising potential for this approach.
Where this research is happening
-
Idt Biologika Gmbh
Dessau-Rosslau, Germany Active
Researchers
- Principal investigator: Neubert, Andreas — Idt Biologika Gmbh
- Study coordinator: Neubert, Andreas
Related research
Other NIH-funded projects on the same topics.
-
Developing new vaccines for infectious diseases and bioterrorism
This study is all about creating new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
-
Creating master cell banks for new SARS-CoV-2 vaccines
This study is working on creating special cell banks to help make better vaccines for COVID-19, which could lead to more effective options for patients in the future.
-
Creating materials for testing new influenza vaccines
This study is working on creating and improving materials for new flu vaccines, which could help keep you and others safer from the flu and similar illnesses.
-
Creating master cell banks for new SARS-CoV-2 vaccines
This study is working on creating special cell banks to help make better vaccines for COVID-19, so that patients can have more effective protection against the virus and its variants.
-
Creating vaccines and biologics to combat infectious diseases
This study is working on creating new vaccines to help protect people from infections like those caused by E. coli, so that patients can have better options for staying healthy and safe from serious diseases.
-
Developing a vaccine using Vero cells for respiratory syncytial virus (RSV)
This study is working on making a safe and effective vaccine to protect babies and young kids from respiratory syncytial virus (RSV), which often causes breathing problems, by improving how the vaccine is produced.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.